These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20352596)

  • 1. [Histopathological diagnose of non-alcoholic and alcoholic fatty liver disease].
    Tannapfel A; Denk H; Dienes HP; Langner C; Schirmacher P; Trauner M; Flott-Rahmel B
    Z Gastroenterol; 2010 Apr; 48(4):486-98. PubMed ID: 20352596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients.
    Tiniakos DG
    Gastroenterol Clin Biol; 2009; 33(10-11):930-9. PubMed ID: 19646834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Grade 2 consensus-based guidelines].
    Tannapfel A; Denk H; Dienes HP; Langner C; Schirmacher P; Trauner M; Flott-Rahmel B
    Pathologe; 2010 May; 31(3):225-37. PubMed ID: 20221762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology and biopsy assessment of non-alcoholic fatty liver disease.
    Straub BK; Schirmacher P
    Dig Dis; 2010; 28(1):197-202. PubMed ID: 20460911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease.
    Tannapfel A; Denk H; Dienes HP; Langner C; Schirmacher P; Trauner M; Flott-Rahmel B
    Virchows Arch; 2011 May; 458(5):511-23. PubMed ID: 21442288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic criteria for non-alcoholic steatohepatitis].
    Hashimoto E
    Nihon Rinsho; 2006 Jun; 64(6):1025-32. PubMed ID: 16768105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.
    Ribeiro PS; Cortez-Pinto H; Solá S; Castro RE; Ramalho RM; Baptista A; Moura MC; Camilo ME; Rodrigues CM
    Am J Gastroenterol; 2004 Sep; 99(9):1708-17. PubMed ID: 15330907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic steatohepatitis in type 2 diabetes mellitus.
    Gupte P; Amarapurkar D; Agal S; Baijal R; Kulshrestha P; Pramanik S; Patel N; Madan A; Amarapurkar A; Hafeezunnisa
    J Gastroenterol Hepatol; 2004 Aug; 19(8):854-8. PubMed ID: 15242486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of non-alcoholic steatohepatitis and basis for treatment.
    Pinzani M
    Dig Dis; 2011; 29(2):243-8. PubMed ID: 21734391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electron microscopic findings in non-alcoholic fatty liver disease: is there a difference between hepatosteatosis and steatohepatitis?
    Ahishali E; Demir K; Ahishali B; Akyuz F; Pinarbasi B; Poturoglu S; Ibrisim D; Gulluoglu M; Ozdil S; Besisik F; Kaymakoglu S; Boztas G; Cakaloglu Y; Mungan Z; Canberk Y; Okten A
    J Gastroenterol Hepatol; 2010 Mar; 25(3):619-26. PubMed ID: 20370732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-alcoholic fatty liver].
    Tagle Arrospide M
    Rev Gastroenterol Peru; 2003; 23(1):49-57. PubMed ID: 12768215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silent non-alcoholic fatty liver disease-a clinical-histological study.
    Sorrentino P; Tarantino G; Conca P; Perrella A; Terracciano ML; Vecchione R; Gargiulo G; Gennarelli N; Lobello R
    J Hepatol; 2004 Nov; 41(5):751-7. PubMed ID: 15519647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
    Sorbi D; Boynton J; Lindor KD
    Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Miele L; Forgione A; Gasbarrini G; Grieco A
    Transl Res; 2007 Mar; 149(3):114-25. PubMed ID: 17320797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
    Pagadala M; Zein CO; McCullough AJ
    Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.
    Federico A; Trappoliere M; Loguercio C
    Dig Liver Dis; 2006 Nov; 38(11):789-801. PubMed ID: 16750661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.